Jay P. Mohr

Columbia University College of Physicians and Surgeons, New York, NY, United States 
behavioral neurology, cerebrovascular disease
"Jay Mohr"
Mean distance: 15.95 (cluster 17)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lee TC, Qian M, Liu Y, et al. (2019) Cognitive Decline Over Time in Patients With Systolic Heart Failure: Insights From WARCEF. Jacc. Heart Failure. 7: 1042-1053
Lee TC, Qian M, Mu L, et al. (2019) Association between mortality and implantable cardioverter-defibrillators by aetiology of heart failure: a propensity-matched analysis of the WARCEF trial. Esc Heart Failure
Di Tullio MR, Qian M, Thompson JLP, et al. (2018) Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatment. Esc Heart Failure
Nakanishi K, Di Tullio MR, Qian M, et al. (2017) Resting Heart Rate and Ischemic Stroke in Patients with Heart Failure. Cerebrovascular Diseases (Basel, Switzerland). 44: 43-50
Ye S, Qian M, Zhao B, et al. (2016) CHA2 DS2 -VASc score and adverse outcomes in patients with heart failure with reduced ejection fraction and sinus rhythm. European Journal of Heart Failure
Di Tullio MR, Qian M, Thompson JL, et al. (2016) Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial. Stroke; a Journal of Cerebral Circulation
Kato TS, Di Tullio MR, Qian M, et al. (2016) Clinical and Echocardiographic Factors Associated With New-Onset Atrial Fibrillation in Heart Failure - Subanalysis of the WARCEF Trial. Circulation Journal : Official Journal of the Japanese Circulation Society
Freudenberger RS, Cheng B, Mann DL, et al. (2015) The first prognostic model for stroke and death in patients with systolic heart failure. Journal of Cardiology
Amory CF, Levine SR, Brey RL, et al. (2015) Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio. Cerebrovascular Diseases (Basel, Switzerland). 40: 293-300
Ye S, Cheng B, Lip GY, et al. (2015) Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin. The American Journal of Cardiology
See more...